RxDoctor Payments Data

Robert Hayashi

Pediatric Hematology-Oncology · Saint Louis, MONPI 1386662062

Payments from drug & device makers

What this record shows

That places this record below the midpoint for pediatric hematology-oncology clinicians in MO, where the typical reported total is $280.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$752,691in research payments, 2019–2025

Across 156 payments — averaging $4824.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Jazz Pharmaceuticals Inc.$490K
  • Merck$123K
  • Janssen Research & Development, LLC$63K
  • E.r. Squibb & Sons, L.L.C.$22K
  • Incyte Corporation$19K
  • Eli Lilly$16K
  • plus $20K from 2 others

How this compares

$0 in reported general payments places this provider in the 5th percentile of 78 pediatric hematology-oncology providers in Missouri.

See all pediatric hematology-oncology providers in Missouri

Other pediatric hematology-oncology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →